Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.31 |
| ▸ | CHRNG | P07510 | 1/20 | 0.31 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179248 | 0.97 | EDNRB (0.34) | EDNRBEDNRAENPP3ENPP1CA12 | |
| SCHEMBL179191 | 0.93 | EDNRB (0.32) | EDNRBEDNRA | |
| SCHEMBL1755412 | 0.91 | GPR84 (0.31) | EDNRBEDNRA | |
| SCHEMBL24618756 | 0.91 | ENPP3 (0.34) | EDNRBEDNRAENPP3ENPP1CA12 | |
| SCHEMBL10358943 | 0.91 | — | — | |
| SCHEMBL12640760 | 0.91 | EDNRB (0.32) | EDNRBEDNRANTSR1HDAC8 | |
| SCHEMBL179122 | 0.90 | GPR84 (0.36) | HDAC8CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL4186277 | 0.89 | HSD17B1 (0.34) | HDAC8 | |
| SCHEMBL10082723 | 0.89 | HSD17B1 (0.35) | HDAC8CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10069124 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120181922-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20120056165-A1 | ORGANIC LUMINESCENT MEDIUM | IDEMITSU KOSAN CO., LTD. | 2012-03-08 | — | — | US | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| US-20110297923-A1 | Aromatic amine derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. | 2011-12-08 | — | — | US | disclosed |
| EP-2163550-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | AOC2, AOC3, H1-4 | EDNRB 286/4885EDNRA 378/4885ENPP3 1577/4885 |
| US-20110297923-A1 | Aromatic amine derivative and organic electroluminescent element using same | H1-4, H1-2, H1-0 | EDNRB 319/4885EDNRA 84/4885ENPP3 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.